Christopher Williams
Managing Director
He/Him
Life at FGS Global
Leads Healthcare communications in London
Life Pre-FGS Global
More than twenty years in communications roles in the US and Europe across multiple sectors. I've worked in pioneering biotech and global pharma companies for a decade and led the global rebrand of French pharma giant Sanofi in 2022.
Life Beyond FGS Global
I am a frequent traveller and a lover of good food, great design and prestige television, especially a good period drama. Palm Springs, California is my happy place.
Chris brings two decades of communications experience to FGS Global, with extensive experience in biotech, pharma and global health. He has led teams in the US, UK and France and his work has spanned corporate communications, corporate brand, media relations, crisis and issues management, business transformation and communication strategies and campaigns to support late-stage clinical biotech and global pharmaceutical companies.
Prior to joining FGS, Chris was Chief Communications Officer at Compass Pathways, a London-based biotech focused on the development of psychedelic drugs for the medical treatment of mental health disorders. He previously held several senior communications roles at the Gates Foundation, supporting its work in global health and development. He was also Vice President of Corporate Communications at Juno Therapeutics and Vice President and Head of Corporate Communications and Brand at Sanofi in Paris, where he led the company's successful global corporate rebrand in 2022.
Earlier in his career, he was a press officer at Goldman Sachs in New York. He earned a master's degree in international relations at the Fletcher School at Tufts University.